Fact CheckerSign in

NCT06874894Enrolling by invitation

Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)

Thromboembolic and Bleeding Risk During Anticoagulant Treatment in Asian Patents With Atrial Fibrillation

Source: ClinicalTrials.gov · Last updated 29 Dec 2025

Brief summary (registry, in English)

This study was design to investigate the efficacy and safety of NOAC therapy in Koreans

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
1021 (estimated)
First submitted
8 Mar 2025
Start date
25 May 2022
Primary completion date
30 Aug 2026
Lead sponsor
Chung-Ang University Hospital
NCT number
NCT06874894

What you commit to

  • Study type: Observational
  • Planned participants: 1021
  • From 25 May 2022 to the primary completion date, 30 Aug 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients with moderate or severe mitral stenosis or mechanical prosthetic valve

Who the study is looking for

  • Patients with documented AF on 12-lead ECG, Holter monitoring, or single-lead ECG recordings are eligible for enrollment.
  • Based on AF treatment Korean guideline 19, AF patients who require NOAC treatment or are currently on NOAC treatment (within the past 3 months)
  • Adults aged 18 or above who have provided consent for clinical information

Age in the registry: 18 months to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chung-Ang University Gwangmyeong Hospital
Coordinator of this site? Confirm its status
GwangmyeongSouth KoreaUnknown status
Chung ang University Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.